Home > Cardiology > AHA 2020 > COVID-19 and Influenza > Unfavourable outcomes for COVID-19 patients with AF and atrial flutter

Unfavourable outcomes for COVID-19 patients with AF and atrial flutter

Presented By
Dr Zaniar Ghazizadeh, Brigham and Women’s Hospital, USA
Conference
AHA 2020
Trial
Yale Cardiovascular COVID Registry

Atrial fibrillation and atrial flutter (AF/FL) are common in hospitalised COVID-19 patients. AF/FL patients had significantly worse outcomes, including lower odds of ICU survival and higher odds of heart failure (HF), acute kidney injury, dialysis, and death/discharge to hospice [1].

These were the main results from a retrospective study of patients from the Yale Cardiovascular COVID Registry, a cohort of adult patients ≥18 years hospitalised with COVID-19 in the Yale New Haven Health System. Medical record review was performed in 396 consecutive patients who were admitted between March and June 2020. Participants' mean age was 68.2 years, 52.3% were men, and 15.7% had a prior history of AF/FL.

A high proportion of patients (19.9%) had in-hospital AF/FL; some of these (7.8%) did not have a prior history of AF/FL. Patients with in-hospital AF/FL had a significantly higher risk of cardiovascular complications compared with those who did not, including...



Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on